Built by patients and drug developers, Jeevan Therapeutics is a seed-stage biotech in Massachusetts developing next-generation medicines for autoimmune diseases. Our lead program for Crohn’s disease is a first-in-class, dual-targeting bispecific nanobody designed to block migration and eliminate the pathogenic cells that drive relapse, with the goal of achieving durable, long-term remission. Alongside this program, we are advancing a broader pipeline of precision biologics and novel therapeutic modalities with potential to address multiple autoimmune conditions where current treatments fall short.

Jeevan Therapeutics

Org chart

Teams

Offices

Jeevan Therapeutics

Org chart

Teams

Offices

Related companies